Editorial: Advances in bioprocessing of viral vectors and virus-like particles

• Philipp Vormittag,
• Michael W. Wolff,
• Michael W. Wolff

Affiliations

Philipp Vormittag

Lonza AG/Ltd, Drug Product Services, Basel, Switzerland

Michael W. Wolff

Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen (THM), Giessen, Germany

Michael W. Wolff

Bioresources, Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Giessen, Germany